LiquidCell Dx is a precision oncology diagnostics company building a blood-based test for tumor microenvironment profiling.  It is well known that patients with the same genomics mutations can have radically different cancer outcomes.  The complex mix of immune cells, stromal context, and the multicellular environment around a tumor shape how a patient's cancer responds to treatment.  LiquidCell Dx is bringing the high resolution needed to comprehensively assess a patient's tumor microenvironment into a blood test simple enough to be incorporated into routine clinical care.

LiquidCell Dx

Org chart

Teams

Offices